Direktorat Registrasi ObatValid

TAZOPIPE COMBINATION FOR IV INFUSION 2,25 (MEIJI)

by '-'

BPOM Number: LKE15153027
Approved: 9 January 2025
Expiry: 18 April 2025
Form: SERBUK INJEKSI LIOFILISASI

About This Registration

TAZOPIPE COMBINATION FOR IV INFUSION 2,25 (MEIJI) is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number LKE15153027. Its current registration status is Valid, with the licence valid until 18 April 2025. The product is registered to MEIJI INDONESIAN PHARMACEUTICAL INDUSTRIES - INDONESIA. BPOM first approved this registration in April 2020. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: newaero
Packaging: DUS, 10 VIAL @ 2.25 G
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

MEIJI INDONESIAN PHARMACEUTICAL INDUSTRIES - INDONESIA
KAB. PASURUAN
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

MEIJI INDONESIAN PHARMACEUTICAL INDUSTRIES - INDONESIA
KAB. PASURUAN
primary
View profile →

Market Intelligence

Owner Portfolio: MEIJI INDONESIAN PHARMACEUTICAL INDUSTRIES - INDONESIA holds 74 BPOM registrations
Manufacturer Scale: MEIJI INDONESIAN PHARMACEUTICAL INDUSTRIES - INDONESIA produces 74 registered products
Registration Age: Registered for 6 years, 5 months
Expiry Status: Expired 524 days ago